465 related articles for article (PubMed ID: 26331456)
1. Metformin use and survival after colorectal cancer: A population-based cohort study.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
[TBL] [Abstract][Full Text] [Related]
2. Metformin use and survival from lung cancer: A population-based cohort study.
Menamin ÚC; Cardwell CR; Hughes CM; Murray LM
Lung Cancer; 2016 Apr; 94():35-9. PubMed ID: 26973204
[TBL] [Abstract][Full Text] [Related]
3. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes.
Vissers PA; Cardwell CR; van de Poll-Franse LV; Young IS; Pouwer F; Murray LJ
Breast Cancer Res Treat; 2015 Apr; 150(2):427-37. PubMed ID: 25762476
[TBL] [Abstract][Full Text] [Related]
4. A cohort study of metformin exposure and survival in patients with stage I-III colorectal cancer.
Spillane S; Bennett K; Sharp L; Barron TI
Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1364-73. PubMed ID: 23753040
[TBL] [Abstract][Full Text] [Related]
5. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G
Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892
[TBL] [Abstract][Full Text] [Related]
6. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
7. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.
Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714
[TBL] [Abstract][Full Text] [Related]
8. The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus.
Lee JH; Kim TI; Jeon SM; Hong SP; Cheon JH; Kim WH
Int J Cancer; 2012 Aug; 131(3):752-9. PubMed ID: 21913184
[TBL] [Abstract][Full Text] [Related]
9. Digoxin use after diagnosis of colorectal cancer and survival: a population-based cohort study.
Karasneh RA; Murray LJ; Hughes CM; Cardwell CR
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1804-7. PubMed ID: 26364159
[TBL] [Abstract][Full Text] [Related]
10. Metformin Increases Overall Survival in Patients with Diabetes Undergoing Surgery for Colorectal Cancer.
Fransgaard T; Thygesen LC; Gögenur I
Ann Surg Oncol; 2016 May; 23(5):1569-75. PubMed ID: 26714936
[TBL] [Abstract][Full Text] [Related]
11. Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus.
Qiu H; Rhoads GG; Berlin JA; Marcella SW; Demissie K
Diabetes Obes Metab; 2013 Apr; 15(4):349-57. PubMed ID: 23137378
[TBL] [Abstract][Full Text] [Related]
12. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.
Calip GS; Yu O; Elmore JG; Boudreau DM
Cancer Causes Control; 2016 May; 27(5):709-20. PubMed ID: 27053250
[TBL] [Abstract][Full Text] [Related]
13. Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients.
Hicks BM; Murray LJ; Hughes C; Cardwell CR
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):830-40. PubMed ID: 26017274
[TBL] [Abstract][Full Text] [Related]
14. Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial.
Tsilidis KK; Capothanassi D; Allen NE; Rizos EC; Lopez DS; van Veldhoven K; Sacerdote C; Ashby D; Vineis P; Tzoulaki I; Ioannidis JP
Diabetes Care; 2014 Sep; 37(9):2522-32. PubMed ID: 24898303
[TBL] [Abstract][Full Text] [Related]
15. Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus.
Marks AR; Pietrofesa RA; Jensen CD; Zebrowski A; Corley DA; Doubeni CA
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1692-8. PubMed ID: 26377195
[TBL] [Abstract][Full Text] [Related]
16. Postdiagnostic metformin use and survival of patients with colorectal cancer: A Nationwide cohort study.
Huang WK; Chang SH; Hsu HC; Chou WC; Yang TS; Chen JS; Chang JW; Lin YC; Kuo CF; See LC
Int J Cancer; 2020 Oct; 147(7):1904-1916. PubMed ID: 32196659
[TBL] [Abstract][Full Text] [Related]
17. Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study.
Horsdal HT; Mehnert F; Rungby J; Johnsen SP
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):717-25. PubMed ID: 21536457
[TBL] [Abstract][Full Text] [Related]
18. Statin use and breast cancer survival: a nationwide cohort study in Scotland.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
BMC Cancer; 2016 Aug; 16():600. PubMed ID: 27491389
[TBL] [Abstract][Full Text] [Related]
19. Metformin and the incidence of viral associated cancers in patients with type 2 diabetes.
Hicks BM; Yin H; Sinyavskaya L; Suissa S; Azoulay L; Brassard P
Int J Cancer; 2017 Jul; 141(1):121-128. PubMed ID: 28393359
[TBL] [Abstract][Full Text] [Related]
20. Medical therapy for diabetes is associated with increased use of lower endoscopy.
Lewis JD; Capra AM; Achacoso NS; Ferrara A; Levin TR; Quesenberry CP; Habel LA
Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1195-202. PubMed ID: 17603822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]